Secondary Prevention Medications: Beta Blockers

Identifying Attributes

Care Settings
Rehabilitation Care
Country
Canada
Publishing Organisation
Grace et al. (2014)
Type of Quality Indicator
Outcome
IOM Quality Dimension
Effectiveness
Domain
Person-Centred Care

Defining Attributes

Definition

Percentage of patients on a beta-blocker at cardiac rehabilitation (CR) discharge.

Numerator

The total number of patients in the CR program who were indicated for and taking beta-blockers at time of CR program discharge. Enrolment is defined as patient attendance at a first CR program visit. Program discharge is defined as patient participated in at least some of the program and the file was closed out by the CR team.

Denominator

The total number of patients indicated for beta-blockers discharged from the CR program. Program discharge is defined as patient participated in at least some of the program and the file was closed out by the CR team.

Exclusions

Denominator, Exclusions: • Patients who died before being discharged from CR program. • Patients who are re-admitted to hospital before being discharged from CR program. • Patients with a documented reason (medical or patient-centred) for not taking beta-blockers.

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Data Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Program databases and/or Canadian Cardiac Rehabilitation Registry.

Frequency of Data Collection
At least annually
Frequency of Data Collection in Days
365
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Grace SL, Poirier P, Norris CM, Oakes GH, Somanader DS, Suskin N. Pan-Canadian development of cardiac rehabilitation and secondary prevention quality indicators. Can J Cardiol. 2014;30(8):945-8.

Link to Measurement Tools

Canadian Association of Cardiovascular Prevention and Rehabilitation Registry (Cardiologica)

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
12 March 2025